News
Pharmaceutical Technology on MSN1d
Third time lucky as PharmaTher gets FDA approval for ketamine
PharmaTher's ketamine product is the first to be approved in an analgesic setting by the FDA, offering competition to opiates ...
The FDA has approved Ketarx, a ketamine-based drug developed by drugmaker PharmaTher, for use in pain management. The medication is now cleared by the FDA for clinical use in perioperative settings, ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company ...
TipRanks on MSN2d
PharmaTher’s KETARx™ Gains FDA Approval, Paving Way for Expansion
PharmaTher Holdings Ltd ( ($TSE:PHRM) ) just unveiled an update. PharmaTher Holdings Ltd. has received FDA approval for its ketamine product, ...
The FDA has approved the racemic ketamine product known as KETARx (PharmaTher Holdings) for the treatment of post-surgical ...
All Penny Stocks (English) on MSN1d
Psychedelic Pharma Stock Surges on FDA Breakthrough
Real-time index price for Nasdaq Industrial Index (INDS), along with buy or sell indicators, analysis, charts, historical ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is focused on the research and commercialization of KETARX™ (Ketamine) to fill the unmet medical needs for surgery, pain, mental health ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is focused on the research and commercialization of KETARX™ (Ketamine) to fill the unmet medical needs for surgery, pain, mental health ...
PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is focused on the research and commercialization of KETARX™ (Ketamine) to fill the unmet medical needs for surgery, pain, mental health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback